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Available online 23 June 2016Background: Epidemiological data strongly suggest that microcephaly cases in Brazil are associated with the on-
going epidemic of Zika virus (ZIKV). In order to further solidify the possible link,we investigated the infectivity of
ZIKV using various neuroblastoma (NB) cell lines.
Methods: Six undifferentiated, two terminally differentiated and two retinoic acid (RA) –induced, partially differ-
entiated cell lines were exposed to ZIKV strain PRVABC59, which is genetically similar to the French Polynesia
strain, with 97–100% genetic homology to the current ZIKV strain found in Brazil. All infections were conﬁrmed
by real-time PCR (RT-qPCR), immunoﬂuorescence assay (IFA) probing with anti-ﬂavivirus E antibody, and eval-
uation of cytopathic effects.
Findings: ZIKV infected all six undifferentiated NB cell lines. In ﬁve out of six NB cell lines, between 90 and 70%
cells were positive by IFA whereas for one cell line, CCL-127, ~80% of cells were positive for ZIKV as determined
by IFA but showed persistent infection. Two differentiated cell lines, JFEN and T-268, were highly resistant to
ZIKV with b1% of the cells being susceptible, as determined by IFA and conﬁrmed by qRT-PCR. Two retinoic
acid (RA)-induced NB partially differentiated cell lines showed no difference in permissiveness as compared to
their undifferentiated mother cell lines.
Interpretation: These ﬁndings strengthen the reported association between high incidences of microcephaly and
ZIKV infection in newborns in Brazil. Our results suggest that the undifferentiated neurons are highly permissive
to ZIKV infection, as one would expect during the early stages of neurogenesis in fetal brains; whereas differen-
tiated neurons, representative of adult brain neurons, are relatively resistant to the virus, which explains the rare
occurrence of neurological complications in adults infected with ZIKV. Our studies conﬁrm the neurotropism of
the ZIKV strain closely related to the current epidemic in Latin America.








Zika virus (ZIKV) is a positive-sense, single-stranded RNA member of
the family Flaviviridae (Mlera et al., 2014). The natural transmission cycle
of ZIKV predominantly involves mosquito vectors from the Aedes genus
andmonkeys (Hayes, 2009), although ZIKV antibodies have been discov-
ered in a number of other animals (Henderson et al., 1968; Kaddumukasa
et al., 2015), including rodents (Darwish et al., 1983). Humans generally
act as infrequent hosts (Kaddumukasa et al., 2015), but may represent a
primary ampliﬁcation and reservoir species in endemic areas (Darwish
et al., 1983). Theﬁrst report of clinicalmanifestations of ZIKVwas inciden-
tal to an outbreak of jaundice in Aﬁkpo, Nigeria in 1954, which was
suspected of being yellow fever (MacNamara, 1954). The virus causes
an acute febrile illness, symptomatically similar to dengue, and is. This is an open access article undercharacterized by mild headache, fever, maculopapular rash, joint and
back pain, and general malaise, sometimes accompanied by conjunctival
hyperemia, anorexia, dizziness, diarrhea and constipation (Dick et al.,
1952; Bearcroft, 1956; Simpson, 1964). The incubation period is between
3 and 12days and symptomsmay last for 2–7 days. Only ~20% of present-
ing patients infectedwith ZIKV exhibit symptoms and the virus has never
been reported to cause hemorrhagic fever or death, often resulting inmis-
diagnosis as dengue (Dick et al., 1952; Bearcroft, 1956; Simpson, 1964).
In early 2015, a serious ZIKV outbreak was recorded in Camaçari,
Bahia, Brazil (Plourde and Bloch, 2016; Cerbino-Neto et al., 2016) and
this was later followed by similar illnesses in ﬁve neighboring states
leading the Ministry of Health to issue a ZIKV alert in April
(Rasmussen et al., 2016; Chan et al., 2016). By the end of the year the
virus had spread through 19 states, many in the northeastern part of
the country. Subsequently, the virus migrated throughout most other
South and Central American countries (Chan et al., 2016) and the pan-
demic swept into the Caribbean with autochthonous transmission inthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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troubling reports of association between ZIKV and infants bornwithmi-
crocephaly, prompted theWHO to issue an “International Health Emer-
gency” on February 1, 2016. Nevertheless, a direct relationship between
ZIKV infection and increased incidence of neurologic disorders and mi-
crocephaly have emerged, and now there is irrefutable evidence to sup-
port a strong link between ZIKV infection and the observed neurologic
defects in newborns (reviewed in 12–14).
Until recently, there have been few reports demonstrating a direct link
between ZIKV infection and congenital Zika syndrome (CZS). Of three
new studies, the recovery of a full length ZIKV genome from an infant
with microcephaly, recovery of ZIKV or positive RNA from amniotic
ﬂuid of an abnormal fetus, and recovery from brain tissues of two fetuses
from ZIKA infected mothers provide convincing evidence for such a link
(reviewed in 12–13). Moreover, in certain instances, impacted regions
of the Brazilian outbreak registered a N10-fold increase in occurrence of
microcephaly; a magnitude surge that cannot be explained by random
clustering. Earlier ZIKVoutbreaks in FrenchPolynesia toohavebeen retro-
spectively strongly associatedwith increased occurrence of microcephaly
(European Centre for Disease Prevention and Control (ECDC), 2015).
Amajor cause for concern is that ZIKV and related virusesmay adapt
to transmission through species of mosquito other than Aedes aegypti.
For example, Aedes albopictus is well established around the Mediterra-
nean in Europe and is present in at least 32 states in the US (Cauchemez
et al., 2016). This species could provide a vector for the onward trans-
mission of ZIKV across both continents that receive viremic returning
travelers (Zammarchi et al., 2015), since there is laboratory evidence
that A. albopictus is a competent vector for the virus (Wong et al.,
2013).Moreover, changes in climatemay contribute to range expansion
for ZIKV and its vectors (Kraemer et al., 2015), and autochthonous cases
in temperate regions may occur even in absence of a competent vector
through sexual transmission (Venturi et al., 2016).
At present, no speciﬁc vaccines or treatments for ZIKV are available
and, although thepossibility exists that presentﬂavivirus vaccine technol-
ogies could be adapted to ZIKV (Rochlin et al., 2013), it is important to in-
vestigate the molecular pathogenesis of the virus. Here, we show that six
human NB cell lines, which behave similarly to a developing human fetal
brain, can be infectedwith ZIKV.We also show that human differentiated
NB neuronal cell lines (JFEN and T-268) are signiﬁcantly resistant to ZIKV.
This report illustrates the differential permissiveness of immature versus
mature human neuron infections from a strain that is genetically similar
to the ZIKV strain responsible for the epidemic in Brazil.2. Material and Methods
2.1. Reagents and Cell Lines
Five NB cell lines were purchased from ATCC (New York, NY). CRL-
2267, CCL-127, CRL-2271 (of male origin) CRL-2266, and CRL- 2149
(of female origin) were cultured in Eagle's Minimum Essential Media
(EMEM) (ATCC,Manassas, VA) supplementedwith 10%heat inactivated
Fetal Bovine Serum (FBS), and L-Glutamine-penicillin-streptomycin so-
lution (designated complete media) (Sigma, St. Louis, MO) at 37 °C, 5%
CO2. SMS-KCNR (of male origin) was purchased from Children's Oncol-
ogy Group (Texas Tech University) and was cultured in RPMI-1640
(Sigma). Two terminally differentiated olfactory neuroblastoma cell
lines, T-268 and JFEN, were a kind gift from Timothy J. Triche (Depart-
ment of Pathology, Children's Hospital of Los Angeles, Los Angeles, CA
90027; 21). The stock cell cultures were grown in 25mL or 75mL ﬂasks
(Thermo-Scientiﬁc, Nunc, Rochester, NY). ZIKV strains PRVABC59 and
MR 766 were provided by the CDC (kind gifts from Brandy Russel,
Fort Collins, CO) and ﬂavivirus envelop antibody (FE1), which cross-re-
acts with ZIKV, was purchased from Invitrogen (Cat. # MA1-71258).
Two NB cell lines CRL-2266 and CRL-2267 were exposed to retinoic
acid (RA) at 1 μM ﬁnal concentration for 48 h (Breitman et al., 1980).Both cell lines exhibited partial differentiation asmeasured by morpho-
logically and by immunostaining with anti-tubulin antibody.
2.2. Propagation of ZIKV
ZIKV strain (KU501215) was propagated in Vero cells (ATCC). The
cells were grown in EMEM to 70% conﬂuency in 25 mL tissue culture
ﬂasks (Nunc Inc., USA). Following removal of the culture media, virus
inoculum was added to give a multiplicity of infection (MOI) of 0.1 to
0.05/cell or 1.0 to 1.5/cell. Flasks were incubated at 37 °C, 5% CO2 with
gentle agitation for 30 min. After incubation, 5 mL of complete media
was added and the cellsweremaintained for 5–9days or until cells exhib-
ited cytopathic effects (CPE). Cells were trypsinized and cryopreserved in
50% FBS and 10% DMSO at−80 °C and used in subsequent studies.
2.3. Infection of Neuroblastoma Cell Lines With ZIKV
To examine the permissiveness of NB cell lines to ZIKV, all 6 undiffer-
entiated cell lines and two olfactory NB cell lines, T-268 and JFEN
(Sorensen et al., 1996), were grown in 25 mL tissue culture ﬂasks to
~70% conﬂuency, media was removed and immediately exposed to an
estimated 0.1 to 0.05 MOI or 1.0 to 1.5 MOI in 1.0 mL serum free
media. For maximum infectivity, the ﬂasks were intermittently gently
agitated for 1 h and then 5mLof pre-warmedmediawas added. Control
cultureswere treated identically, except no ZIKVwas added to the inoc-
ula. The cells were incubated at 37 °C, 5% CO2. The cell cultures were ob-
served every 12 h for CPE and images recorded on a digital microscope
camera. Each experiment was repeated at least three times for lowMOI
and twice for high MOI infected cells.
2.4. Immunoﬂuorescence Assay (IFA)
For immunocytochemical studies, each cell linewas grown in 8-well
chamber slides (Thermo Scientiﬁc, Nunc, Rochester, NY) with ~1 × 105
cells in 0.3 μL of media for 4–7 days. For seeding the NB cell lines, the
stock cell cultures grown in the ﬂasks were gently washed once with
1× PBS followed by trypsinization until single cell suspension and inac-
tivation of trypsin with 1 mL FBS. The cells were counted on a hemocy-
tometer chamber and adjusted to 1 × 105 cells/mL. The 8-well chamber
slides were labeled, 100 μL of cells were then added to each well of the
respective 8-well chamber slides, and 1 μL of fresh media was added
containing 0.1–0.05 MOI of the virus. After 1 h of incubation, the cells
were washed gently and 500 μL of fresh media was added. After 48 h
culture, the media was removed from the slides and the cells were
ﬁxed by adding 800 μL of Streck Tissue Fixative (STF, Streck Laboratories
Inc., LA Vista, NE), a non-ionic ﬁxative, in each well and allowed to set
overnight at 4 °C. The wells were then washed gently three times
using 1× sterile Phosphate Buffered Saline (PBS) (Fisher Scientiﬁc, Fair
Lawn, NJ) and then soaked with the blocking agent (containing 2% Bo-
vine Serum Albumin (BSA) in 1× PBS) for 10 min. ZIKV was detected
by utilizing mouse monoclonal antibody to ﬂavivirus (Cat. # MA1-
71258, Invitrogen). All antibody dilutions were carried out in 2% BSA
in 1× PBS. The primary Ab was diluted to 1:10 in blocking buffer. In
each chamber, 100 μL of diluted primary Ab was added to each well.
The slides were incubated at 4 °C overnight in a humidiﬁed chamber
and then washed three times in 1× PBS. Then, goat anti-mouse ﬂuores-
cein conjugated secondary Ab was used at a working dilution of 1:40
with 100 μL in each well. The slides were incubated for 1 h at 37 °C in
humidiﬁed chambers and then washed three times with PBS with
10min incubation each time. The tops of the 8-well chamberwere care-
fully removed without disturbing the ﬁxed cells. The cells were washed
in PBS three times and thenmountedwith glass coverslips, using a drop
of mounting solution containing 50% glycerol, 50% PBS. The slides were
observed at resolutions 10×, 40×, and 1000× (with oil) using anOlym-
pus BX51 ﬂuorescent microscope. Each experiment was repeated at
least three times with low MOI and two times with high MOI of ZIKV.
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2.5. Real-Time PCR (RT-PCR)
The ZIKV RNA copies were quantiﬁed using one-step RT-PCR. Viral
RNA was extracted from culture pellet using GenElute Mammalian
Total RNA Miniprep kit (Sigma, St. Louis, MO) according to the
manufacturer's protocol. Two sets of primer pairs were designed to tar-
get the 5′UTR region of the virus genome (Forward primer, ZIKV_F, 5′-
TTGGTCATGATACTGCTGATTGC-3′ and reverse primer, ZIKV_R, 5′-
CCTTCCACAAAGTCCCTATTGC-3′) and (Forward primer, Zika E_F, 5′
AAGTTTGCATGCTCCAAGAAAAT-3′ and reverse primer, Zika E_R,-5′
CAGCATTATCCGGTACTCCAGAT-3′). The reactions of qRT-PCR were car-
ried out using iScript One-step RT-PCR kit with SYBR Green (Bio-Rad,
Hercules, CA) and quantiﬁcation was performed using ABI 7500 real-
time cycler (Applied Biosystems, Foster City, CA). The thermal cycling
proﬁle of this assay consisted of a 10 min cDNA synthesis step at 50 °
C, 5 min of iScript reverse transcriptase inactivation at 95 °C, followed
by 35 cycles of PCR at 95 °C for 10 s and a step of a single ﬂuorescence
emission data collection at 59 °C for 30 s. Each experimentwas repeated
three times with lowMOI and two times with highMOI of ZIKV. Results
were analyzed using HID Real-Time PCR Analysis Software v1.2 (Ther-
mo Scientiﬁc,Waltham,MA). Relative degree of ZIKV replications in dif-
ferent cell lines were calculated using cycle threshold values (Ct).
3. Results
3.1. Real-Time PCR and Immunoﬂuorescence Assay
In order to determine incidence of ZIKV infection in NB cell lines, a
presence/absence assay was conducted by RT-PCR. Analysis for pres-
ence of ZIKV showed positive infection of all six undifferentiated NB
cell lines. The same, uninfected, cell lines were used as controls, which
showed an absence of ZIKV RNA (Table 1). Cell lines CRL-2266, CRL-
2267, CRL-2271, CRL-2149, CCL-127, and SMS-KCNR showed positive
infection by ZIKV, whereas the controls were negative for ZIKV. There
were no signiﬁcant differences in the degree of permissiveness of ZIKV
between NB cell lines of male and female origin (Table 1). Statistical
analyses were carried out using GraphPad Prism software (San Diego,
CA) by unpaired Student's t-test. An immunoﬂuorescence assay, with
anti-ﬂavivirus envelope IgG, conﬁrmed the RT-PCR results (Table 1
and Fig. 1). Two differentiated neuronal cell lines, JFEN and T-268,
showed signiﬁcant resistance to ZIKV, as evaluated by RT-PCRs and
IFA (Fig. 1). Also, when cell lines CRL-2266 and CRL-2267were partially
differentiated via 48 h RA exposure, there were no signiﬁcantTable 1
Percent of ZIKV-infected neuroblastoma cells as determined by immunoﬂuorescence as-
say and conﬁrmed by RT-PCR.
Cell line ZIKV+ RT-PCR Remarks
CRL-2266 81%–85% 4+a Immature, progenitor neurons
CRL-2267 67%–72% 4+ Immature, progenitor neurons
CRL-2271 84%–93% 4+ Immature, progenitor neurons
CRL-2142 90%–97% 4+ Immature, progenitor neurons
CCL-127 83%–86% 4+ Immature, progenitor neurons
SMS-KCNR 81%–89% 4+ Immature, progenitor neurons
JFEN b1%–3% 1+ Differentiated neurons
T-268 b1% 1+b Differentiated neurons
CRL-2266-RA 53%–78% 4+ Partially differentiated with ~31% of cells with
long axons
CRL-2267-RA 61%–69% 4+ Partially differentiated with ~22% of cells with
long axons
a 4+ is designated when the ampliﬁcation line for a specimen crosses the threshold
between 15 and 20 cycles.
b 1+ is designated when the ampliﬁcation line for a specimen crosses the threshold
between 33 and 35 cycles.differences in ampliﬁcation, as compared to the undifferentiated NB
cell lines infected with ZIKV. RA induced partial differentiation in the
progenitor NB cells where ~31% of the neurons exhibited elongated
axons in CRL-2266 and ~22% of the neurons showed elongated axons
in CRL-2267 (Supplemental Fig. 1). The RT-PCR results also conﬁrmed
that therewasno signiﬁcant decrease in permissiveness to ZIKV as com-
pared to the immature parental NB cell lines. Suppressed growth rate
and morphological evidence, such as increased neuritic processes, con-
ﬁrmed partial differentiation. The presence or absence of ZIKV in all of
the aforementioned cell lines was further conﬁrmed by utilization of
two sets of primer pairs by RT-PCR and agarose gel electrophoresis, in
which NB cells showed presence of ZIKV RNA produced by RT-PCR
with expected bands of 76 and 72 base pairs. There were no signiﬁcant
differences in the percentage of cells infected with low MOI (0.1–0.05
MOI) versus highMOI (1.0 to 1.5), suggesting that permissiveness is re-
lated to the receptor-mediated entry of ZIKV (Hamel et al., 2015).
3.2. Morphological Study
All the NB infected cell lineswere observed twice a day post-infection.
The CPE was discernable within 24 h post-infection, when the neurons
began to round up and ﬂoat on top of themonolayers.Wewere surprised
by the speed with which ZIKV infection spread throughout the monolay-
er, within 48 h post infection, and a signiﬁcant percentage of cells in al-
most all the cell lines showed cell death, as measured by the Eosin-Y
viability test (Supplemental Fig. 2). The infection with ZIKV produced
acute lytic effects in all six immature NB cell lines. These cell lines exhib-
ited CPE and neurons with highly abnormal morphology, including neu-
rons showing elongation of cells, vacuolation within the cytoplasm,
enlargement of the neuronal cell body, shortening, thinning or abnormal
increase of axonal length, change in cellular diameter, central chromatol-
ysis, and other abnormal cellular morphology (Fig. 2). The surviving im-
mature cells were re-cultured in fresh media, and only one cell line,
CCL-127, began to replicate but exhibited obvious evidence of CPE, includ-
ing occasional giant cells (Fig. 2). This cell line has beenmaintained for the
last 3months. It shows persistent infection that is documented by RT-PCR
and IFA (data not shown). All six NB cell lines showed low viability after
48 h, whereas two mature cell lines, JFEN and T-268, expressed no clear
morphological changes andappear to be resistant to the cytopathic effects
of ZIKV. Therefore, even 12 weeks post-infection, the cells grew at a sim-
ilar growth rate to uninfected cells. The twomatureNB cell lines appeared
normal and without any apparent CPE. Immunostaining with ﬂavivirus E
Ab, as well as RT-PCR, conﬁrmed the relative resistance to ZIKV (Table 1;
Fig. 1).
In summary, in all types of NB cell lines, ZIKV infection induced
marked and signiﬁcant changes of the neurons and caused neuronal pro-
liferation, central chromatolysis, enlargement of the neuronal cell body,
shortening or abnormal increase and thinning of axonal length, syncytia
formation, and neurostimulations or selective neurocytotoxicity.
4. Discussion
Since January 2007 ZIKV outbreaks have been documented in 61
countries and, in 57 of these, the epidemic continues (http://www.
who.int/emergencies/zika-virus/situation-report/21-april-2016/en/).
The speed atwhich the virus has spread serves to highlight inherent de-
ﬁciencies in emergency preparedness and response protocols for many
infected countries; especially as this relates to emerging diseases.
Mounting evidence points to ZIKV being sexually transmitted and it
has been associated with a variety of neurological syndromes including
Guillain-Barré Syndrome (GBS), meningitis, myelitis, and meningoen-
cephalitis (European Centre for Disease Prevention and Control
(ECDC), 2015; Cauchemez et al., 2016). The existence of a link between
fetal defects, microcephaly, and ZIKV infection during pregnancy is
strong (Rasmussen et al., 2016). The results presented herein serve to
Fig. 1. Immunoﬂuorescence assay utilizing a cross acting ﬂavivirus monoclonal antibody to detect ZIKV envelope antigen expression on the cell surface of ZIKV infected and uninfected
neuroblastoma cell lines. (Top row, left to right) A) CCL-127 uninfected; B) CCL-127 ZIKV infected; C) CRL-2266 uninfected; D) CRL-2266 ZIKV infected; E) CRL-2142 uninfected; F)
CRL-2142 ZIKV infected; G) CRL-2267 uninfected; H) CRL-2267 ZIKV infected; I) CRL-2271 uninfected; J) CRL-2271 ZIKV infected; K) SMS-KCNR uninfected; L) SMS-KCNR ZIKV
infected; M) JFEN uninfected; N) JFEN ZIKV infected; O) T-268 uninfected; P) T-268 ZIKV infected.
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tion induced marked and signiﬁcant CPE in neurons.
We did not ﬁnd any difference in the percent of NBC infected with
low or high MOI by IFA or RT-PCR. ZIKV could potentially use DC-SIGN
and phosphatidylserine receptors, such as T-cell immunoglobulin andFig. 2.Morphological analyses by utilizing H&E staining. (Top row, left to right) A) CCL-127 uni
CRL-2142 uninfected; F) CRL-2142 ZIKV infected; G) CRL-2267 uninfected; H) CRL-2267 ZIKV
SMS-KCNR ZIKV infected; M) JFEN uninfected; N) JFEN ZIKV infected; O) T-268 uninfected, P)
ZIKV infection induced changes of the neurons and showed neuronal proliferation, central c
shortening or abnormal increase and thinning of axonal length, syncytia formation, and neuromucin domain (TIM) and TYRO3, AXL, and MER (TAM; Hamel et al.,
2015; Meertens et al., 2012), or perhaps CD300a (Simhadri et al.,
2012), to gain access or adhere to cells. Accordingly, our results suggest
that available receptors, if this represents the sole mechanism of entry,
were fully occupied even at the low MOI. As illustrated herein, ZIKV isnfected; B) CCL-127 ZIKV infected; C) CRL-2266 uninfected; D) CRL-2266 ZIKV infected; E)
infected; I) CRL-2271 uninfected; J) CRL-2271 ZIKV infected; K) SMS-KCNR uninfected; L)
T-268 ZIKV infected. All the infected cells, except JFEN and T-268, are showing signiﬁcant
hromatolysis, enlargement of the neuronal cell body, vacuolation within the cytoplasm,
stimulations or selective neurocytotoxicity.
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hence, once a pregnantwoman becomes viremic, there is high potential
that the infectionwill reach fetal brain neurons. It appears that themost
vulnerable stage of infection for the fetus is before 17 weeks of gesta-
tion, after which the risk to the unborn child is low (Carneiro and
Travassos, 2016). TYRO3, a member of the TAM family of receptor tyro-
sine kinases (RTKs), is abundant on the surface of neurons and appears
to be the prime target for ZIKV (Rothlin and Lemke, 2010), a possibility
that seems justiﬁed given that the brains of sucklingmice infected with
ZIKV express neuronal degeneration, cellular inﬁltration, and softening,
with evidence of virus replication in astroglial cells and neurons on his-
topathological examination (Rothlin and Lemke, 2010; Bell et al., 1971).
However, we speculate that the entry receptors for ZIKV are absent or
signiﬁcantly downregulated in the mature, terminally differentiated
neuroblastoma cell lines, blocking the viral entry to these neurons.
This possibility would need further investigation (Bell et al., 1971).
Dysregulation of neuronal cell cycling following in vitro ZIKV infection
has also been observed usingﬂowcytometric and transcriptome analyses
by Tang et al. (2016). Interestingly, the speed of cell contagion in the
study described herein was more rapid than that observed by Tang et
al. (36 h versus 66–72 h). Thismay have resulted due to differences in ex-
perimental design, cultured cells employed (induced pluripotent stem
cells derived from human skin cells versus human fetal brain progenitor
neurons derived from childhood neuronal crest cells (neuroblastoma;
30). Also we used the ZIKV strain that is genetically similar to the current
Brazilian strain of ZIKV (MR766 versus PRVABC59; Zhu et al., 2016;
Nunes et al., 2016). Other morphological changes associated with ZIKV
infection included syncytia and giant cell formation, which generally re-
sults due to the expression of viral fusion proteins (Lee and Bowden,
2000), and central chromatolysis, wherein chromatin and cell nuclei
were dislocated to the cell's periphery, indicating general injury. Enlarge-
ment of the neuronal cell body and shortening or abnormal increase and
thinning of axonal length were also observed. The latter abnormalities
represent common defects encountered during other viral infections in-
cluding rubella, cytomegalovirus, herpes, and West Nile virus (Hamel et
al., 2015; Stewart et al., 2013; O'Leary et al., 2006; Watrin et al., 2016).
Therewas nodifference betweenmale and femaleNB cell lines, even
though there was male predominance with a sex ratio of 2.82 in the in-
cidence of Guillain-Barré Syndrome (GBS) during the ZIKV epidemic in
French Polynesian Islands (Whitman and Greer, 2009). Furthermore,
we did not observe a signiﬁcant difference between theundifferentiated
and partially differentiated NBCs (RA-induced neurons). This may sug-
gest that, after RA exposure, the cell lines were not terminally differen-
tiated and still need additional steps for terminal differentiation
(Kovalevich and Langford, 2013).
The ﬁndings described here may explain the permissiveness of de-
veloping immature progenitor neurons, aswell as the relative resistance
of mature neurons found in adult human brains, to ZIKV. Our studies
also point to a relative vulnerability of replicating and regenerating neu-
rons to ZIKV, such as the olfactory and dentate gyrus of the adult human
brain (Whitman and Greer, 2009). Of note, the French Polynesian out-
break of ZIKVwas remarkable because 74 infected individualswere pre-
sented with neurological symptoms, of which 47 were later diagnosed
with GBS (Cauchemez et al., 2016; Hamel et al., 2015). Even though
GBS is generally considered to be the result of autoantibodies to the pe-
ripheral nervous system antigen, inﬂammation of dentate gyrus has
been reported (Müller et al., 2003). This may explain why GBS is rather
infrequent, whereas microcephaly is more common during ZIKV infec-
tions. Of note, we have to also realize that warming climate may in-
crease the range of mosquito and other vector-mediated transmission
of many diseases, including ZIKV (Liu-Helmersson et al., 2016).
The limitation of the current study is that we have utilized NBC lines
andnot actual humanprenatal subjects,whichwould be unethical. Also,
there are inﬁnite differences between in vivo development of progeni-
tor cells in a fetal brain and in the in vitro environment, as employed
herein. However, we believe that despite these limitations, we presenta clear picture of permissiveness of undifferentiated versus terminally
differentiated neurons.
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